Cargando…

Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase

OBJECTIVE: To observe the influence of Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin (HCG) carrying heparanase (Hpa) antisense oligodeoxynucleotide (ASODN), via the invasion, proliferation, and Hpa expression of JEG-3 cell lines and inhibitory effect of transplanted choriocarcinoma tumor gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Huining, Liu, Yi, Zhang, Dihong, Tang, Yifeng, Pan, Man, Xia, Ting, Yang, Jingting, Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826771/
https://www.ncbi.nlm.nih.gov/pubmed/24235832
http://dx.doi.org/10.2147/IJN.S44739
_version_ 1782290959533342720
author Huining, Liu
Yi, Zhang
Dihong, Tang
Yifeng, Pan
Man, Xia
Ting, Yang
Jingting, Cai
author_facet Huining, Liu
Yi, Zhang
Dihong, Tang
Yifeng, Pan
Man, Xia
Ting, Yang
Jingting, Cai
author_sort Huining, Liu
collection PubMed
description OBJECTIVE: To observe the influence of Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin (HCG) carrying heparanase (Hpa) antisense oligodeoxynucleotide (ASODN), via the invasion, proliferation, and Hpa expression of JEG-3 cell lines and inhibitory effect of transplanted choriocarcinoma tumor growth. METHODS: The different abilities of invasion and proliferation between transfected JEG-3 and untransfected JEG-3 were measured by Matrigel invasion assay and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay in vitro. The effect of Hpa ASODN transfection on the expression of Hpa mRNA and protein was measured by reverse-transcription polymerase chain reaction and Western blot. The transplanted choriocarcinoma tumors were taken out to calculate the inhibitory effect on tumor growth of Hpa ASODN. RESULTS: In this study, we found that: (1) the invasive ability of JEG-3 cells was inhibited sufficiently (P < 0.05) after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN; (2) after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN at 48 and 72 hours, the proliferative ability of JEG-3 cells was inhibited sufficiently (P < 0.05); (3) the expression of Hpa mRNA and protein in JEG-3 cells was inhibited efficiently after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN (P < 0.05); and (4) Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN had an inhibitory effect on the transplanted choriocarcinoma tumor growth (P < 0.05) and was harmless on nude mice. CONCLUSION: Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN weakened the invasive and proliferative ability of choriocarcinoma, with a significant inhibitory effect on the transplanted choriocarcinoma tumor. Therefore, Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN is an effective gene therapy, and Fe(3)O(4)-dextran-anti-βHCG nanoparticles are a harmless and effective gene vector.
format Online
Article
Text
id pubmed-3826771
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-38267712013-11-14 Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase Huining, Liu Yi, Zhang Dihong, Tang Yifeng, Pan Man, Xia Ting, Yang Jingting, Cai Int J Nanomedicine Original Research OBJECTIVE: To observe the influence of Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin (HCG) carrying heparanase (Hpa) antisense oligodeoxynucleotide (ASODN), via the invasion, proliferation, and Hpa expression of JEG-3 cell lines and inhibitory effect of transplanted choriocarcinoma tumor growth. METHODS: The different abilities of invasion and proliferation between transfected JEG-3 and untransfected JEG-3 were measured by Matrigel invasion assay and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay in vitro. The effect of Hpa ASODN transfection on the expression of Hpa mRNA and protein was measured by reverse-transcription polymerase chain reaction and Western blot. The transplanted choriocarcinoma tumors were taken out to calculate the inhibitory effect on tumor growth of Hpa ASODN. RESULTS: In this study, we found that: (1) the invasive ability of JEG-3 cells was inhibited sufficiently (P < 0.05) after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN; (2) after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN at 48 and 72 hours, the proliferative ability of JEG-3 cells was inhibited sufficiently (P < 0.05); (3) the expression of Hpa mRNA and protein in JEG-3 cells was inhibited efficiently after JEG-3 cells were transfected by Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN (P < 0.05); and (4) Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN had an inhibitory effect on the transplanted choriocarcinoma tumor growth (P < 0.05) and was harmless on nude mice. CONCLUSION: Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN weakened the invasive and proliferative ability of choriocarcinoma, with a significant inhibitory effect on the transplanted choriocarcinoma tumor. Therefore, Fe(3)O(4)-dextran-anti-βHCG carrying Hpa ASODN is an effective gene therapy, and Fe(3)O(4)-dextran-anti-βHCG nanoparticles are a harmless and effective gene vector. Dove Medical Press 2013 2013-11-06 /pmc/articles/PMC3826771/ /pubmed/24235832 http://dx.doi.org/10.2147/IJN.S44739 Text en © 2013 Huining et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Original Research
Huining, Liu
Yi, Zhang
Dihong, Tang
Yifeng, Pan
Man, Xia
Ting, Yang
Jingting, Cai
Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase
title Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase
title_full Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase
title_fullStr Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase
title_full_unstemmed Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase
title_short Inhibition of choriocarcinoma by Fe(3)O(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase
title_sort inhibition of choriocarcinoma by fe(3)o(4)-dextran-anti-β-human chorionic gonadotropin nanoparticles containing antisense oligodeoxynucleotide of heparanase
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826771/
https://www.ncbi.nlm.nih.gov/pubmed/24235832
http://dx.doi.org/10.2147/IJN.S44739
work_keys_str_mv AT huiningliu inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase
AT yizhang inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase
AT dihongtang inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase
AT yifengpan inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase
AT manxia inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase
AT tingyang inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase
AT jingtingcai inhibitionofchoriocarcinomabyfe3o4dextranantibhumanchorionicgonadotropinnanoparticlescontainingantisenseoligodeoxynucleotideofheparanase